International Journal of Trichology International Journal of Trichology
 Print this page Email this page Small font sizeDefault font sizeIncrease font size
 
 
  Home | About IJT | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submission | Subscribe | Advertise | Contact us | Login   
 


 
 Table of Contents  
CASE REPORT
Year : 2010  |  Volume : 2  |  Issue : 2  |  Page : 106-107  

Turban PUVASOL: An effective treatment in alopecia totalis


Department of Dermatology, PSG Hospitals, Coimbatore, Tamil Nadu, India

Date of Web Publication9-Mar-2011

Correspondence Address:
C Shanmuga Sekar
Department of Dermatology, PSG Hospitals, Peelamedu, Coimbatore - 641 004, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-7753.77520

Rights and Permissions
   Abstract 

Alopecia areata is characterized by patchy hair loss involving the scalp, eyelashes, and beard. The disease may at times lead to complete baldness of the scalp (alopecia totalis) or of the entire body (alopecia universalis). Alopecia totalis is usually resistant to therapy. We report two cases of alopecia totalis treated with turban psoralen with sunlight exposure (PUVASOL).

Keywords: Alopecia totalis, PUVASOL, Turban


How to cite this article:
Sornakumar L, Sekar C S, Srinivas C R. Turban PUVASOL: An effective treatment in alopecia totalis. Int J Trichol 2010;2:106-7

How to cite this URL:
Sornakumar L, Sekar C S, Srinivas C R. Turban PUVASOL: An effective treatment in alopecia totalis. Int J Trichol [serial online] 2010 [cited 2020 Jul 3];2:106-7. Available from: http://www.ijtrichology.com/text.asp?2010/2/2/106/77520


   Introduction Top


Alopecia totalis is a distressing problem which is usually resistant to various therapeutic modalities. PUVA therapy is an effective therapeutic option but is associated with side effects such as nausea, requires eye protection, and cannot be used in children. Through use of 'turban PUVASOL', it is now possible to administer a dilute bathwater solution containing 8-methoxypsoralen (8-MOP) to the scalp. We report two cases of alopecia totalis which responded to turban PUVASOL (psoralen with sunlight exposure).


   Case Reports Top


Case 1

A 41-year-old woman presented with complete loss of scalp hair since 12 months [Figure 1]. The diagnosis was confirmed by biopsy. She was treated with minoxidil 10% twice daily and 4 mg of betamethasone twice weekly for 6 months with no significant response. She was further treated with turban PUVASOL therapy as described below. After 2 months, vellus hair started growing and by 4 months, she had significant hair growth [Figure 2].
Figure 1: Complete loss of scalp hair

Click here to view
Figure 2: Regrowth of scalp hair after 6 months

Click here to view


In the turban PUVASOL therapy, 1 ml of 8-methoxypsoralen (8-MOP) 1% was diluted in 2 l of water. A clean absorbent cotton cloth was soaked into the solution for 30 seconds and wrapped around the scalp in a turban-like fashion for 5 minutes. The process was repeated four times. The patients were further exposed to sunlight for 5 minutes and the time was gradually increased up to 15 minutes. The treatment was carried out thrice a week. The time of exposure was between 10:00 and 10:15 AM when the ultraviolet (UV)A : UVB ratio is maximum. The patient was advised to avoid sun exposure for few hours after treatment.

Case 2

An 8-year-old boy presented with complete loss of hair over the scalp since 20 months. The diagnosis was confirmed by histopathology. He was treated for 1 year with 2 mg of betamethasone twice weekly and minoxidil 5% twice daily with no significant response. We decided to treat the patient with turban PUVASOL therapy similar to previous case. The patient started having vellus hair growth after 2 months and by 6 months there was almost complete regrowth of scalp.


   Discussion Top


Alopecia areata (AA) is an autoimmune disease characterized by patchy, nonscarring hair loss. Although it most commonly affects the scalp, it can involve any hair-bearing area on the body. Alopecia totalis refers to complete loss of scalp hair. AA can lead to severe emotional distress. Various therapeutic modalities such as systemic steroids, contact immunotherapy, and phototherapy have been tried with partial success.

In 1974, Rollier and Warcewski [1] induced hair regrowth in a patient with AA using 8-MOP and natural sunlight. The first report of PUVA treatment with artificial UVA light for AA was published in 1978 by Weissman et al.[2] who obtained encouraging results in five patients.

The turban PUVA can be considered a variation of the so called bath suit PUVA method as described by Pai and Srinivas. [3] It has the advantage of delivering the desired photosensitizing effect in a localized area without systemic side effects. Behrens-Williams et al. [4] reported hair regrowth in six of nine patients after 10 weeks of treatment. Broniarczyk-Dyla et al. [5] observed that turban PUVA was significantly more effective in AA vulgaris than in AA totalis or universalis and proved to be a safe, well-tolerated method without the systemic side effects of PUVA.

Our patients were not able to come regularly for turban PUVA treatment and hence we decided to modify it as turban PUVASOL. The mechanism of action of PUVA in AA is not clearly understood. There is circumstantial and indirect evidence that AA is a T cell-mediated autoimmune disease of the hair follicle. Immunohistochemical studies in human beings and animal models have demonstrated a perifollicular accumulation of dendritic cells plus CD4+ and CD8+ T lymphocytes and isolated polymorphonuclear cells. [6] Because dendritic cells are thought to play an important role in the initiation of AA by antigen presentation and costimulation, PUVA treatment might exert an inhibitory effect on the development of AA. Suppression of IL-2 and IL-1ß production might suppress an already present lymphocytic infiltrate in AA and induce hair growth.

The time chosen for phototherapy was between 10:00 and 10:15 AM. Balasaraswathy et al. [7] in a study proved that the ideal time for PUVASOL is between 9:15 and 11:15 AM, which will minimize unwanted exposure to UVB and infrared radiation and hence we regularly advise this particular time in our institute. Both our patients had significant improvement after therapy. We report this case as the effectiveness of turban PUVASOL in AA has never been reported.

 
   References Top

1.Rollier R, Warcewski Z. Le traitement de la pelade par la meladinine. Bull Soc Fr Dermatol Syph 1974;81:97.  Back to cited text no. 1
    
2.Weissman I, Hofmann C, Wagner G. PUVA therapy for alopecia areata: An investigative study. Arch Dermatol Res 1978;262:333-6.  Back to cited text no. 2
    
3.Pai S, Srinivas CR. Bathing suit delivery of 8 - methoxypsoralen for psoriasis: A double-blind, placebo-controlled study. Int J Dermatol 1994;33:576-8.  Back to cited text no. 3
    
4.Behrens-Williams SC, Leiter U, Schiener R, Weidmann M, Peter RU, Kerscher M. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata. J Am Acad Dermatol 2001;44:248-52.  Back to cited text no. 4
[PUBMED]  [FULLTEXT]  
5.Broniarczyk - Dyla G, Wawrzycka - Kaflik A, Dubla - Berner M, Prusinska-Bratos M. Effects of psoralen-UV-A - Turban in alopecia areata. Skinmed 2006;5:64-8.  Back to cited text no. 5
    
6.McElwee KJ, Tobin DJ, Bystryn JC, King LE Jr, Sundberg JP. Alopecia areata: An autoimmune disease? Exp Dermatol 1999;8:371-9.  Back to cited text no. 6
[PUBMED]    
7.Balasaraswathy P, Kumar U, Srinivas CR, Nair S. UVA and UVB in sunlight: Optimal utilization of UV rays in sunlight for phototherapy. Indian J Dermatol Venereol Leprol 2002;68:198-201.  Back to cited text no. 7
[PUBMED]  Medknow Journal  


    Figures

  [Figure 1], [Figure 2]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
    Introduction
    Discussion
    Case Reports
    References
    Article Figures

 Article Access Statistics
    Viewed3341    
    Printed110    
    Emailed3    
    PDF Downloaded110    
    Comments [Add]    

Recommend this journal